Target Price | $62.89 |
Price | $62.99 |
Deviation | 0.15% |
Number of Estimates | 19 |
19 Analysts have issued a price target Monster Beverage 2026 . The average Monster Beverage target price is $62.89. This is 0.15% lower than the current stock price. The highest price target is $72.00 14.30% , the lowest is $49.00 22.21% . | |
A rating was issued by 25 analysts: 13 Analysts recommend Monster Beverage to buy, 9 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Monster Beverage stock has an average upside potential 2026 of 0.15% . Most analysts recommend the Monster Beverage stock at Purchase. |
19 Analysts have issued a sales forecast Monster Beverage 2025 . The average Monster Beverage sales estimate is $7.9b . This is 6.53% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $8.1b 8.35% , the lowest is $7.7b 3.86% .
This results in the following potential growth metrics:
2024 | $7.5b | 4.94% |
---|---|---|
2025 | $7.9b | 5.90% |
2026 | $8.6b | 7.93% |
2027 | $9.1b | 6.81% |
2028 | $10.3b | 12.50% |
2029 | $11.2b | 9.27% |
14 Analysts have issued an Monster Beverage EBITDA forecast 2025. The average Monster Beverage EBITDA estimate is $2.4b . This is 17.95% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.5b 28.93% , the lowest is $2.3b 16.94% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $2.1b | 3.31% |
---|---|---|
2025 | $2.4b | 19.84% |
2026 | $2.6b | 8.93% |
2027 | $2.8b | 8.16% |
2028 | $3.2b | 13.84% |
2024 | 27.48% | 1.55% |
---|---|---|
2025 | 30.37% | 13.17% |
2026 | 30.65% | 0.92% |
2027 | 31.04% | 1.27% |
2028 | 31.40% | 1.16% |
10 Monster Beverage Analysts have issued a net profit forecast 2025. The average Monster Beverage net profit estimate is $1.8b . This is 22.49% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 25.12% , the lowest is $1.7b 16.34% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.5b | 3.25% |
---|---|---|
2025 | $1.8b | 24.14% |
2026 | $2.0b | 11.91% |
2027 | $2.2b | 9.43% |
2028 | $2.7b | 22.20% |
2024 | 19.39% | 7.80% |
---|---|---|
2025 | 22.73% | 17.22% |
2026 | 23.57% | 3.70% |
2027 | 24.15% | 2.46% |
2028 | 26.23% | 8.61% |
10 Analysts have issued a Monster Beverage forecast for earnings per share. The average Monster Beverage EPS is $1.85 . This is 22.52% higher than earnings per share in the financial year 2024. The highest EPS forecast is $1.91 24.84% , the lowest is $1.78 16.34% .
This results in the following potential growth metrics and future valuations:
2024 | $1.49 | 3.25% |
---|---|---|
2025 | $1.85 | 24.16% |
2026 | $2.07 | 11.89% |
2027 | $2.27 | 9.66% |
2028 | $2.77 | 22.03% |
Current | 41.59 | 21.96% |
---|---|---|
2025 | 34.06 | 18.11% |
2026 | 30.43 | 10.66% |
2027 | 27.81 | 8.61% |
2028 | 22.76 | 18.16% |
Based on analysts' sales estimates for 2025, the Monster Beverage stock is valued at an EV/Sales of 7.54 and an P/S ratio of 7.74 .
This results in the following potential growth metrics and future valuations:
Current | 8.03 | 11.53% |
---|---|---|
2025 | 7.54 | 6.16% |
2026 | 6.98 | 7.35% |
2027 | 6.54 | 6.38% |
2028 | 5.81 | 11.11% |
2029 | 5.32 | 8.49% |
Current | 8.25 | 7.40% |
---|---|---|
2025 | 7.74 | 6.13% |
2026 | 7.17 | 7.35% |
2027 | 6.72 | 6.38% |
2028 | 5.97 | 11.11% |
2029 | 5.46 | 8.49% |
Monster Beverage...
Analyst | Rating | Action | Date |
---|---|---|---|
Roth MKM |
Neutral
➜
Neutral
|
Unchanged | May 14 2025 |
CICC |
Market Perform
➜
Outperform
|
Upgrade | May 12 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | May 09 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | May 09 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | May 09 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | May 05 2025 |
Truist Securities |
Sell
➜
Sell
|
Unchanged | Apr 24 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Roth MKM:
Neutral
➜
Neutral
|
May 14 2025 |
Upgrade
CICC:
Market Perform
➜
Outperform
|
May 12 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
May 09 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
May 09 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
May 09 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
May 05 2025 |
Unchanged
Truist Securities:
Sell
➜
Sell
|
Apr 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.